US2004192911A1PendingUtilityA1
Process for the preparation of an indole derivative
Est. expiryJul 16, 2018(expired)· nominal 20-yr term from priority
C07D 209/42
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process for the preparation of methyl 2-(3-chloropropoxy)-indole-3-carboxylate, which comprises reacting a 3-chloro-3-carboxylate indole compound with 3-chloropropanol in the presence of an acid having a pKa of from 0 to 2.
Claims
exact text as granted — not AI-modified1 and 2 (Cancelled)
3 . A process for preparing N-[(1- n butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide, i.e. the compound of Formula (I):
or a pharmaceutically acceptable salt thereof, which process comprises
(a) preparing methyl 2-(3-chloropropoxy)-indole-3-carboxylate, i.e. the compound of formula (B):
by reacting a compound of formula (C)
with 3-chloropropanol in the presence of an acid having a pKa of from 0 to 2; and
(b) using the resulting methyl 2-(3-chloropropoxy)-indole-3-carboxylate of formula (B) in the next stage in the synthesis of the N-[(1- n butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide or the pharmaceutically acceptable salt thereof.
4 . A process as claimed in claim 3 wherein in step (a) the acid is trichloroacetic acid, dichloroacetic acid and/or trifluoroacetic acid.
5 . A process as claimed in claim 3 wherein in step (a) the acid is trichloroacetic acid.
6 . A process as claimed in claim 3 wherein the reaction in step (a) is effected in an organic solvent.
7 . A process as claimed in claim 6 wherein in step (a) the organic solvent is dichloromethane or chloroform.
8 . A process as claimed in claim 3 wherein the reaction in step (a) is effected in an organic solvent at a temperature in the range −20° C. to +10° C.
9 . A process as claimed in claim 4 wherein the reaction in step (a) is effected in an organic solvent at a temperature in the range −20° C. to +10° C.
10 . A process as claimed in claim 8 wherein in step (a) the organic solvent is dichloromethane or chloroform.
11 . A process as claimed in claim 9 wherein in step (a) the organic solvent is dichloromethane or chloroform.
12 . A process as claimed in claim 6 wherein the reaction in step (a) is effected using a catalytic amount of the acid.
13 . A process as claimed in claim 8 wherein the reaction in step (a) is effected using a catalytic amount of the acid.
14 . A process as claimed in claim 9 wherein the reaction in step (a) is effected using a catalytic amount of the acid.
15 . A process as claimed in claim 11 wherein the reaction in step (a) is effected using a catalytic amount of the acid.
16 . A process as claimed in claim 3 comprising, in step (b), cyclisation of the intermediate (B) (the methyl 2-(3-chloropropoxy)-indole-3-carboxylate) by treatment with base in a solvent to prepare a compound of formula (A):
wherein R is methyl, which compound of formula (A) is methyl 3,4-dihydro-2H-[1,3]-oxazino[3,2-a]indole-10-carboxylate.
17 . A process as claimed in claim 16 , comprising, in step (b): reacting N-(1- n butyl-4-piperidyl)methylamine with the methyl 3,4-dihydro-2H-[1,3]-oxazino[3,2-a]indole-10-carboxylate of formula (A) to prepare the N-[(1- n butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide of formula (I); and
optionally preparing a pharmaceutically acceptable salt of the N-[(1- n butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide.
18 . A process as claimed in claim 13 comprising, in step (b), cyclisation of the intermediate (B) (the methyl 2-(3-chloropropoxy)-indole-3-carboxylate) by treatment with base in a solvent to prepare a compound of formula (A):
wherein R is methyl, which compound of formula (A) is methyl 3,4-dihydro-2H-[1,3]-oxazino[3,2-a]indole-10-carboxylate.
19 . A process as claimed in claim 18 , comprising, in step (b): reacting N-(1- n butyl-4-piperidyl)methylamine with the methyl 3,4-dihydro-2H-[1,3]-oxazino[3,2-a]indole-10-carboxylate of formula (A) to prepare the N-[(1- n butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide of formula (I); and
optionally preparing a pharmaceutically acceptable salt of the N-[(1- n butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide.
20 . A process as claimed in claim 3 , wherein step (b) comprises preparing the hydrochloride salt of N-[(1- n butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide.
21 . A process as claimed in claim 13 , wherein step (b) comprises preparing the hydrochloride salt of N-[(1- n butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide (SB-207266-A).
22 . A process as claimed in claim 17 , wherein step (b) comprises preparing the hydrochloride salt of N-[(1- n butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide (SB-207266-A).
23 . A process as claimed in claim 19 , wherein step (b) comprises preparing the hydrochloride salt of N-[(1- n butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide.Join the waitlist — get patent alerts
Track US2004192911A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.